Paindrainer AB, the developer of a drug-free digital medical device for chronic pain management, has raised $640K in seed funding.
The company's Paindrainer® platform is an FDA-registered and CE-certified mobile application that leverages advanced algorithms and a patented "360° patient-centricity©" feature. Founded in 2018, Paindrainer provides personalized guidance to help users manage their pain and achieve an improved functional level, also offering a Care Portal for healthcare professionals to remotely monitor patient treatment.
